H.R. 2090 (109th): Food and Drug Administration Improvement Act of 2005


May 4, 2005
109th Congress, 2005–2006

Died in a previous Congress

This bill was introduced on May 4, 2005, in a previous session of Congress, but was not enacted.


Maurice Hinchey

Representative for New York's 22nd congressional district



Read Text »
Last Updated: May 4, 2005
Length: 19 pages

About the bill

Full Title

To amend the Federal Food, Drug, and Cosmetic Act to provide for the deposit in the general fund of the Treasury of fees that are collected from manufacturers of drugs and devices under chapter VII of such Act, to terminate the authority of the Food and Drug Administration to negotiate with the manufacturers on particular uses of the fees, to establish a Center for Postmarket Drug Safety and Effectiveness, to establish additional authorities to ensure the safe and effective use of drugs, and for other purposes.

Summary (CRS)

5/4/2005--Introduced.Food and Drug Administration Improvement Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require that all fees collected for the review of applications for ... Read more >

The bill’s title was written by its sponsor.


May 4, 2005

This is the first step in the legislative process.

This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 2090”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


15 cosponsors (14D, 1I) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: